The biggest concern with Redux is an increased risk of primary pulmonary hypertension
June 1996
The biggest concern with Redux is an increased risk of primary pulmonary hypertension. This is serious...high blood pressure in the lungs can lead to heart failure and death.
Many patients are asking about this...especially after the sensationalized program on PrimeTime Live.
This risk is associated with using ANY of the prescription appetite suppressants for more than 3 months. This includes Redux as well as fenfluramine, phentermine, etc.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote